Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate

Following completion of the full set of clinical studies, Dr Reddy's said it will now prepare to file in the US, European Union and other regions for approval of 'DRL_RI'.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news